Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017
Aug 31, 2017 11:00 am UTC| Business
Positive CHMP Opinion for Lutetium Lu 177 Dotatate* (Lutathera®) for GEP-NETS FDA Acknowledged Receipt and Completeness of NDA Resubmission for Lutetium Lu 177 Dotatate* (Lutathera®) and Provided PDUFA Date of January...
Codexis to Present at Four Investment Conferences in September
Aug 31, 2017 11:00 am UTC| Business
REDWOOD CITY, Calif., Aug. 31, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September: BioCentury 24th Annual...
REGENXBIO to Present at Upcoming Investor Conferences
Aug 31, 2017 11:00 am UTC| Business
ROCKVILLE, Md., Aug. 31, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...
Financial Gravity Names Todd Bourgeois to Advisory Board
Aug 31, 2017 11:00 am UTC| Business
ALLEN, Texas, Aug. 31, 2017 -- Financial Gravity Companies, Inc. (OTCQB:FGCO), is pleased to welcome Todd Bourgeois as the newest Advisory Board Member. ...
Neato Launches Flagship Robot Vacuum - Botvac D7™ Connected
Aug 31, 2017 11:00 am UTC| Business
NEWARK, Calif., Aug. 31, 2017 -- IFA - Neato Robotics, leader in smart robots for the home, today announced the launch of Neato Botvac D7™ Connected, the most powerful, intuitive and connected robot vacuum you will ever...
Sunesis to Present at Upcoming Investor Conferences
Aug 31, 2017 11:00 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2017 -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the company will present at two upcoming investor conferences. Daniel Swisher, Chief Executive Officer...
Curis Announces CA-170 Poster Presentation at ESMO 2017 Congress
Aug 31, 2017 11:00 am UTC| Business
LEXINGTON, Mass., Aug. 31, 2017 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today...